Ignite Creation Date:
2024-05-06 @ 2:56 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04470973
Status:
UNKNOWN
Last Update Posted:
2022-09-10
First Post:
2020-07-09
Brief Title:
Pharmacokinetics of Amikacin and Cefuroxime in Critically Ill Patients
Sponsor:
Organization:
Radboud University Medical Center
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Blood samples and 24 hours urine will be collection following an intravenous gift of either cefuroxime or amikacin
Enrollment Count:
40
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 66796 |
Who Masked List: